BRAND_ANALYSIS #NOVO_NORDISK HEALTH & PHARMA #25 OF 26 IN HEALTH & PHARMA ALIGNED

Novo Nordisk

· Public · Updated 04 Oct 2026 09:24 UTC
#1144 of 1208 overall by tension · #25 of 26 in Health & Pharma
4 Aligned
The Balanced
Analysis

Pharma as culture war. C=57, B=61, sentiment 0.60, stock -20.21%. Novo Nordisk's GLP-1 empire performs commercially but remains culturally contested (obesity as moral vs. medical). The sentiment premium is fragile.

IN THE NEWS (100 articles this week)
Patients switching to Novo Nordisk's Wegovy pill from shots lose more weight in real-world study - Reuters
Novo Nordisk Just Beat Lilly in a Trial. Is the Comeback Finally Taking Shape? - Yahoo Finance
Novo agrees $2.6B deal for preclinical GLP-1/GIP drug from in-demand Hengrui - Fierce Biotech
Cultural Score
57 / 100
Business Score
61 / 100
TREND
TENSION▂▃▂▂▂▁▁▂▁▂▁▁▁▁
CULTURAL▄▄▄▄▄▄▄▄▄▄▄▄▄▄
BUSINESS▆▆▆▆▆▅▅▅▅▅▅▅▅▅
TREND CHART
Loading...
CULTURAL BREAKDOWN
Wikipedia Momentum 15/40
News Presence 43/35
Search InterestRedistributed to other dimensions
BUSINESS BREAKDOWN
Stock Momentum 4/30
Market Position 22/25
Revenue Growth 15/25
Earnings Health 20/20
STOCK DATA
Price$37.32
30d Change-20.2%
Market Cap$164.8B
Profit Margin35.4%
BRANDS LIKE THIS
Banksy
C:55 B:59 T:4
Infosys
C:55 B:59 T:4
Snap
C:55 B:59 T:4
DoorDash
C:57 B:60 T:3
Airbus
C:60 B:64 T:4
SHARE
Novo Nordisk's tension is 4. Commerce outpacing culture. sociologyofcapitalism.com/brand/novo-nordisk
SHARE ON X
EMBED
<iframe src="https://sociologyofcapitalism.com/embed/novo-nordisk.html" width="320" height="200" frameborder="0"></iframe>
Data: Wikipedia Pageviews, Google News RSS, AI Sentiment, Yahoo Finance
All scores approximate. Updated weekly.
Sociology of Capitalism
Mike Litman